Crestor in Canada: prescription, pharmacy and pricing
Crestor (Rosuvastatin) is available in Canada under the regulatory framework of Health Canada. This page summarises how the medication is prescribed and dispensed locally, what insurance or the public system cover, and which options exist for legally and safely accessing Crestor 5mg, 10mg, 20mg, 40mg.
- Regulator
- Health Canada
- Currency
- CAD
- Active ingredients
- Rosuvastatin
- Available dosages
- 5mg, 10mg, 20mg, 40mg
Prescription status in Canada
Canada classifies medications as Schedule I (prescription), II (pharmacist-only OTC), III (open OTC) or unscheduled, with provincial variation. Provincial drug plans cover prescription costs at varying rates. Crestor contains the active ingredient Rosuvastatin, in the Cardiovascular Medications class, and its classification in Canada follows the standard rules of Health Canada.
Pharmacy dispensing
Canadian pharmacies (Shoppers Drug Mart, Rexall, London Drugs and many independents) are licensed provincially, and pharmacists in several provinces can prescribe for minor ailments. The pharmacist is the most reliable local source of information on stock, authorised substitutions (generic vs brand) and specific precautions for Crestor at the available strengths (5mg, 10mg, 20mg, 40mg).
Online and tele-prescribing access
Online pharmacy is regulated provincially in Canada; cross-border imports are restricted. Tele-prescribing platforms have expanded prescription access since 2020. Buying Crestor from unauthorised sellers or without local verification exposes the user to counterfeit medication and unmonitored use of Rosuvastatin.
When Crestor is prescribed
Crestor is approved in adults for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia, for the prevention of cardiovascular events in patients at elevated risk and for the secondary prevention of cardiovascular events.
Pricing and availability in CAD
Retail pricing in Canada depends on the strength (5mg, 10mg, 20mg, 40mg), whether the original brand or an authorised generic is dispensed, and insurance or public-system coverage. The difference between brand and generic is usually the most meaningful economic lever for ongoing use. Comparing prices at two or more locally authorised pharmacies before first refill is recommended.
Frequently asked questions
Do I need a prescription for Crestor in Canada? ▾
Canada classifies medications as Schedule I (prescription), II (pharmacist-only OTC), III (open OTC) or unscheduled, with provincial variation. Provincial drug plans cover prescription costs at varying rates. In practice, Crestor follows the status of its active ingredient Rosuvastatin in the regulatory system of Health Canada.
Is generic Crestor available in Canada? ▾
Authorised generics of Rosuvastatin are typically available in Canada at a lower cost than branded Crestor, with bioequivalence required by Health Canada. Substitution is handled by the pharmacist under local equivalence rules.
How much does Crestor cost in CAD? ▾
Prices in CAD vary by pharmacy and by strength (5mg, 10mg, 20mg, 40mg). Authorised generics of Rosuvastatin are usually substantially cheaper than the brand and are the typical economic reference point for ongoing use in Canada.
Crestor in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- South KoreaMFDS (Ministry of Food and Drug Safety)
- JapanPMDA (Pharmaceuticals and Medical Devices Agency)
- AustriaBASG (Federal Office for Safety in Health Care)
- SwitzerlandSwissmedic (Swiss Agency for Therapeutic Products)
- AustraliaTGA (Therapeutic Goods Administration)
- ColombiaInvima (National Food and Drug Surveillance Institute)
- ChileISP (Instituto de Salud Pública de Chile, Public Health Institute)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.